Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...
Olivia Matyus has said her baby Ingrid suffered months of untreated seizures and now hopes additional stem therapy abroad ...
People whose brain age is older than their actual chronological age by 10 years may have a 39% higher future risk of dementia ...
Partnership strengthens Headsafe’s U.S. commercialization with established contracting, logistics, and distribution ...
Researchers monitored participants' brain activity to understand how expert echolocators are able to perceive the location of ...
Chatting with a friend in a noisy restaurant? New research says you’re probably not doing yourself any favors if you close ...
AI is a fork in the road disguised as a shortcut.
Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral ...
A research paper by scientists from Pohang University of Science and Technology developed a groundbreaking silent speech ...
Why are some people unable to hear from birth, even though their inner ear appears intact? One possible cause lies in the ...
Even a brief time spent on a bedside pedal device has positively impacted an area of the brain related to memory, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results